|
ИСТИНА |
Войти в систему Регистрация |
ФНКЦ РР |
||
Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current statusстатья
- Авторы: Kiseleva Yana V., Maslennikov Roman V., Gadzhiakhmedova Aida N., Zharikova Tatyana S., Kalinin Dmitry V., Zharikov Yury O.
- Журнал: World journal of hepatology
- Том: 15
- Номер: 2
- Год издания: 2023
- Издательство: Baishideng
- Местоположение издательства: Beijing, China, China
- Первая страница: 208
- Последняя страница: 215
- DOI: 10.4254/wih.v15.i2.208
- Аннотация: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, leading to fibrosis, cirrhosis and hepatocellular carcinoma and also associated with increased cardiovascular disease mortality. The pathogenesis of NAFLD is not fully understood, although NAFLD is thought to be a hepatic form of metabolic syndrome. There is an increasing understanding of the role of microbiota disturbances in NAFLD pathogenesis, and as with many other conditions affecting the microbiota, NAFLD may be a novel risk factor for Clostridioides difficile (C. difficile) colonization (CDC) and C. difficile infection (CDI). CDI is an emerging nosocomial disease, and community-acquired cases of infection are growing, probably due to an increase in CDC rates. The association of NAFLD with CDI has been shown in only 4 studies to date, three of which included less than 1000 patients, although the frequency of NAFLD in these studies was observed in almost 20% of the total patient cohort. These data revealed that NAFLD is a risk factor for CDI development and, moreover, is a risk factor for intestinal complications of CDI. More studies are needed to investigate this association and move forward CDC and CDI screening efforts for this group of patients.
- Добавил в систему: Жарикова Татьяна Сергеевна